CCF Celebrates Major Milestone in Connecting Patients and Caregivers to Mentorship Program

September 2023, Vol 4, No 3

The Cholangiocarcinoma Foundation (CCF) is celebrating the 1000th mentor–mentee match and 6 years of their mentoring program, CholangioConnect. CCF has developed unique resources to help patients and caregivers navigate their healthcare journeys.

Cholangiocarcinoma (CCA) is a type of cancer that forms in the bile ducts of the liver. With approximately 10,000 cases of CCA being diagnosed in the United States each year, bile duct cancer is the second most common primary liver cancer in the world. It is often diagnosed at advanced stages when treatment is minimally effective, emphasizing the urgent need for novel therapies and strong patient support.

CCF’s CholangioConnect creates personalized connections that enable one-on-one support among CCA patients, survivors, and caregivers. New members are connected to a mentor who has personal experience with the disease and can offer support at any stage in the CCA management journey. The CholangioConnect program has expanded to meet the needs of patients and caregivers and is offering mentorship to those living in the United States and 31 other countries.

Karla Boyden, CCA patient/survivor, and Carla Anderson, CCA patient/survivor

“Our CholangioConnect staff have a keen sense of what our patients and caregivers need and match them with mentors who have walked in their shoes,” said Stacie Lindsey, CCF’s Founder and CEO. “We celebrate the 1000-strong connections made over the past 6 years while also focusing on innovative research that leads to new treatments and a cure, and strengthening the support network that improves the quality of life of patients.”

Patty Maxin, caregiver to her husband Mike Lu who passed away in 2015, became CholangioConnect’s first program manager. She has also served as a patient and research advocate and on the CCF Board of Directors. “Patients and caregivers give selflessly in order to walk alongside others who are in need of a helping hand, an ear, or just the confirmation that they are not in this alone,” Maxin said of the CholangioConnect mentors.

CholangioConnect mentors receive training and support materials and are assigned mentees who they support through phone calls, email, and participation in virtual support groups.

Mentoring services are tailored to fit the needs of the mentees and time and availability of the mentors. “Mentors of CholangioConnect understand by experience, the fear and loneliness of this diagnosis, as all volunteers have a personal relationship with bile duct cancer,” Maxin said.

“Profound bonds are forged, and mentorships give way to lasting friendships that are sometimes only possible when both parties emotionally respond to a common adversity. They show us courage and the opportunity to witness humanity at its best.”

Rob Howard provided care to his father who was battling CCA. Howard was paired with a mentor through CholangioConnect, and now he provides the same support to other caregivers. “The truth is simple: The CholangioConnect program fundamentally changed how I navigated the uncertain and scary world of my dad’s diagnosis,” Howard said. “My initial phone call with my mentor lasted over an hour, and I went from feeling scared and alone, to feeling informed, hopeful, and better equipped to face the uncertain times ahead for my dad and our family.” Completing 1000 connections between mentors and mentees means 1000 patients and caregivers have received strong emotional support, tailored resources, and a support network. It also underscores the need for life-saving treatments.

In celebrating 6 successful years of CholangioConnect, CCF is expanding the program to serve even more people in need of support. To learn more about CholangioConnect and to be assigned or become a mentor, visit https://cholangiocarcinoma.org/cholangioconnect/.

Related Items

The 13th Annual Cholangiocarcinoma Foundation Conference is Approaching!
March 2026, Vol 7, No 1
The Cholangiocarcinoma Foundation (CCF) is thrilled to announce the upcoming 13th Annual Cholangiocarcinoma Foundation Conference, set to take place in Salt Lake City, UT, from May 1-3, 2026, with a virtual option also available.
Cholangiocarcinoma Foundation Announces Upcoming Regional Symposia
December 2025, Vol 6, No 4
The Cholangiocarcinoma Foundation (CCF) is pleased to announce a series of upcoming regional symposia designed to bring together patients, caregivers, clinicians, researchers, and advocates from across the country.
2025 Chicago Cholangiocarcinoma Symposium
September 2025, Vol 6, No 3
The 2025 Chicago Cholangiocarcinoma Symposium, hosted by Dr Anjana Pillai and Dr Andy Liao, will take place on Friday, September 26, from 8:00 am to 4:00 pm, at the Knapp Center for Biomedical Discovery in Chicago, IL.
Shaping the Future of Research: A Recap of the 12th Annual Cholangiocarcinoma Foundation Conference
June 2025, Vol 6, No 2
The Cholangiocarcinoma Foundation 12th Annual Conference marked a milestone in global collaboration. It brought together scientists, academic researchers, advocates, industry partners, patients, and caregivers to identify the top research priorities in cholangiocarcinoma.
Connect Patients With Cholangiocarcinoma to Essential Educational Videos
March 2025, Vol 6, No 1
The Cholangiocarcinoma Foundation is providing a video series for patients and caregivers. Patients can access informational videos through electronic health records.
CCF’s 12th Annual Conference: Driving Research Priorities for Cholangiocarcinoma Breakthroughs
December 2024, Vol 5, No 4
The 12th annual conference, International Consensus on Research Priorities, aims to accelerate breakthroughs in understanding and treating cholangiocarcinoma by identifying top research priorities through collaboration among patients, caregivers, and experts in 10 specialized working groups.
CCF Funding Part of Important Study and Publication
September 2024, Vol 5, No 3
Dr Bardeesy has contributed significantly to understanding and treating CCA, a rare and aggressive cancer of the bile ducts. He has worked with the Cholangiocarcinoma Foundation (CCF) in multiple capacities, is a CCF Science and Medical Advisory Board emeritus member, and is currently participating in the Cure Cholangiocarcinoma Think Tank (C2T2).
The 11th Annual CCF Conference Is Approaching
March 2024, Vol 5, No 1
The Cholangiocarcinoma Foundation (CCF) will host the 11th Annual CCF Conference in Salt Lake City, Utah, from April 17 to 19. This article summarizes the conference’s itinerary, overarching goals, and participating speakers.
11th Annual CCF Foundation Conference Set for April 2024
December 2023, Vol 4, No 4
The Cholangiocarcinoma Foundation (CCF) is pleased to announce the 11th Annual Cholangiocarcinoma Foundation Conference in Salt Lake City, UT, April 17-19, 2024.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Profession or Role
Primary Specialty or Disease State